ABSTRACTBACKGROUNDVirtual Reality (VR) is being applied as a clinical tool to engage and educate patients during their neurosurgery consultation for various skull base and pituitary tumor pathologies.OBJECTIVETo assess the impact of VR implementation on patient satisfaction, understanding and comfort level, shared decision making, and surgical conversion using a 2-fold study.METHODSPatient feedback was collected after consultations with patient-specific VR renderings by Surgical Theater in a prospective survey study. A retrospective review of 257 new patients was also conducted to determine the impact of VR implementation on surgical conversion and patient outmigration rates.RESULTSPatients reported significantly higher ratings for overall satisfaction, understanding of their medical condition and treatment plan, and how well the physician communicated during the VR consultation compared to prior consultation(s). The Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores for physician communication, hospital rating, and hospital recommendation were 23%, 24%, and 23%, respectively, higher than the national average. A 32% improvement in patient retention and conversion rates resulted from consultations with patient-specific VR models of their lesions (P < .0001).CONCLUSIONThese findings indicate that VR is a powerful tool for enhancing patient engagement and education.
As part of the work of the Symposium a workshop was convened to consider the potential role of, and issues arising from, the expansion of previously political intelligence agencies into fighting international, organised economic (entrepreneurial) crime.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.